Loading...
XJPX7775
Market cap93mUSD
Jan 14, Last price  
512.00JPY
1D
-1.16%
1Q
1.39%
Jan 2017
-36.32%
IPO
216.05%
Name

Daiken Medical Co Ltd

Chart & Performance

D1W1MN
XJPX:7775 chart
P/E
14.88
P/S
1.51
EPS
34.41
Div Yield, %
3.90%
Shrs. gr., 5y
-0.40%
Rev. gr., 5y
3.01%
Revenues
9.75b
+6.71%
4,608,452,0005,181,784,0005,739,369,0006,242,357,0006,515,255,0007,068,350,0007,635,801,0008,033,054,0008,261,416,0008,399,605,0008,585,276,0008,406,607,0008,523,354,0007,861,969,0008,540,443,0009,137,102,0009,750,166,000
Net income
989m
+38.84%
317,373,000369,494,000487,503,000555,058,000404,108,000787,543,000881,497,0001,097,854,0001,153,281,0001,246,001,0001,012,144,000851,600,000859,547,000675,231,000831,056,000712,062,000988,602,000
CFO
1.56b
+57.26%
133,491,000613,181,000551,536,000920,778,000254,180,0001,211,669,000995,060,0001,140,020,0001,294,996,0001,350,353,0001,255,103,000880,925,0001,436,905,000609,170,0001,133,623,000989,156,0001,555,500,000
Dividend
Mar 28, 20250 JPY/sh

Profile

Daiken Medical Co., Ltd. manufactures and distributes medical devices and equipment in Japan and internationally. The company offers syringe pumps, disposable infusion pumps, portable disposable infusers, endobronchial blocker tubes, suction containers, connecting tubes, suction tips, medical hand washing machines, disposable medical towels, sterilize mats, and wet disinfectant mats. It also trades in medical equipment. The company sells its products under the COOPDECH brand. Daiken Medical Co., Ltd. was incorporated in 1968 and is headquartered in Izumi, Japan.
URL
https://daiken-iki.co.jp/
IPO date
Mar 12, 2009
Employees
188
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
9,750,166
6.71%
9,137,102
6.99%
8,540,443
8.63%
Cost of revenue
8,256,902
8,027,941
5,679,482
Unusual Expense (Income)
NOPBT
1,493,264
1,109,161
2,860,961
NOPBT Margin
15.32%
12.14%
33.50%
Operating Taxes
447,857
312,962
320,280
Tax Rate
29.99%
28.22%
11.19%
NOPAT
1,045,407
796,199
2,540,681
Net income
988,602
38.84%
712,062
-14.32%
831,056
23.08%
Dividends
(573,955)
(565,320)
(574,296)
Dividend yield
3.60%
4.09%
3.92%
Proceeds from repurchase of equity
(1,000)
BB yield
0.00%
Debt
Debt current
1,486,196
1,690,140
1,614,987
Long-term debt
647,717
1,055,802
1,343,511
Deferred revenue
Other long-term liabilities
12,462
17,133
17,260
Net debt
(627,185)
164,730
386,909
Cash flow
Cash from operating activities
1,555,500
989,156
1,133,623
CAPEX
(168,803)
(199,049)
(203,216)
Cash from investing activities
(168,767)
(210,526)
(196,237)
Cash from financing activities
(1,163,804)
(781,007)
(589,439)
FCF
2,392,161
774,809
2,533,516
Balance
Cash
2,739,141
2,516,212
2,518,589
Long term investments
21,957
65,000
53,000
Excess cash
2,273,590
2,124,357
2,144,567
Stockholders' equity
7,758,998
8,046,604
7,895,588
Invested Capital
6,878,994
6,923,271
6,951,263
ROIC
15.15%
11.48%
35.93%
ROCE
16.32%
12.26%
31.45%
EV
Common stock shares outstanding
28,728
28,728
28,728
Price
555.00
15.38%
481.00
-5.69%
510.00
-16.26%
Market cap
15,944,284
15.38%
13,818,380
-5.69%
14,651,505
-16.26%
EV
15,317,099
13,983,110
15,038,414
EBITDA
1,709,412
1,376,456
3,175,384
EV/EBITDA
8.96
10.16
4.74
Interest
4,825
3,965
3,737
Interest/NOPBT
0.32%
0.36%
0.13%